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Volume 50, Number 6 Abstracts 1541Conclusions: The use of prophylactic R-IVCFs after multisystem
trauma is increasing; most are not removed. This case report demonstrates
that R-IVCFsmay be associated with significant risks.We urge caution in the
prophylactic use of R-IVCFs until there are data demonstrating the benefit
of such a management strategy.
Bilateral Renal Vein Thrombosis Treated with Percutaneous Throm-
bolysis and Mechanical Thrombectomy
JarrodD.Day, Brian L. Chen, and JeanM. Panneton, FromEastern Virginia
Medical School. Norfolk, Va
Background: Renal vein thrombosis is a rare phenomenon with sig-
nificant morbidity. Management usually consists of systemic anticoagula-
tion, yet with the evolution of endovascular technology, more novel treat-
ment options have been described. We report a case illustrating our
approach.
Methods: A 34-year-old previously healthy Caucasian man presented
to the emergency department with gradual onset of bilateral flank abdominal
pain and anuria. Initial evaluation revealed only proteinuria, but before the
initiation of hemodialysis, he underwent an abdominal/pelvic computed
Fig 2. Reformatted 3-dimensional computed tomography scan
image of the retrievable inferior vena cava filter shows extraluminal
struts and aortic pseudoaneurysm.Fig. Venography confirms inferior vena cava filter placementtomography (CT) scan. This demonstrated an extensive thrombus involving
both renal veins and extending proximally into the juxtarenal inferior vena
cava (IVC). After the initiation of heparin, the patient underwent suprarenal
IVC filter placement through a transjugular approach. This was followed by
IVC venography through a femoral approach, confirming the aforemen-
tioned results (Fig), and selective bilateral renal venography starting first
with the right renal vein. Pulse spray thrombolysis using tissue plasminogen
activator (tPA; 1.5 mg) was performed, followed by mechanical thrombec-
tomy with the AngioJet catheter. Repeat renal venography demonstrated
patency. Pulse spray thrombolysis was repeated in a similar fashion for the
IVC (3.5 mg tPA) and left renal system (2 mg tPA) with subsequent
AngioJet thrombectomy. The final venogram revealed residual clot burden
in both renal veins; therefore, separate catheters were selectively placed in
both renal veins and treated with continuous tPA infusion at 0.5 mg/h
(total, 1 mg/h) for 12 hours in addition to systemic heparinization.
Results: Venography 12 hours later demonstrated excellent flow
through both renal systems and the IVC. Heparin therapy was maintained,
which was eventually converted to oral anticoagulation. He maintained
excellent urine output, and his creatinine levels trended back towards
baseline. In addition, his glomerular filtration rate dramatically improved
throughout his hospitalization. Renal duplex ultrasound imaging before
discharge again demonstrated excellent flow through both renal venous
systems and the IVC. His renal function remained stable almost a year after
the event, and he has remained dialysis-free.
Conclusions: Percutaneous mechanical thrombectomy and thrombol-
ysis is an alternative therapeutic option for renal vein thrombosis, which can
be performed with good technical success and, in this patient, provided
successful renal salvage and excellent early clinical outcomes.
Management of a Thoracic Aortic Coarctation Presenting as Severe
Hypertension and Increasing Dyspnea on Exertion
Hernan A. Bazan, Bruce Torrance, and Larry H. Hollier, From Louisiana
State University Health Sciences Center School of Medicine. New Orleans,
La
Background: Adult thoracic aortic coarctation is universally fatal by
the fifth decade if left untreated, primarily due to the accelerated arterioscle-
rosis. Repair of this rare thoracic pathology in adults presents several tech-
nical challenges due to thickness of the aortic wall, difficulties in aortic arch
mobilization, large intercostal arteries, and poststenotic aneurysm forma-
tion. There is a paucity of discussion of thoracic coarctation in the vascular
literature; however, various repair approaches have been advocated in the
cardiothoracic literature, including end-to-end anastomosis, path angio-
plasty repair, and subclavian-to-thoracic aorta bypass.
Methods:Amorbidly obese (bodymass index, 48 kg/m2) 35-year-old
woman with hypertension, increasing buttock claudication to50 feet, and
dyspnea on exertion was referred to our center for evaluation of a recently
found thoracic aortic coarctation. Despite taking four antihypertensive
medications, the patient’s hypertension was poorly managed. A pressure
gradient 110 mm Hg was present between the brachial and femoral
arteries (210 vs 100 mmHg, respectively). Computed tomography angiog-
raphy (CTA) of the thorax and abdomen demonstrated the coarctation just
distal to the left subclavian artery (Fig 1), a small abdominal aorta (10
mm), and a large cohort of chest and abdominal wall collaterals emanating
Fig 1. Computed tomography demonstrates the coarctation just
distal to the left subclavian artery.
